AKT1 and breast cancer: Notably, circARL8B silencing also inhibits the PGE2/PI3K/AKT/GSK-3β/Wnt/β-catenin pathway, ultimately suppressing BC cell survival, movement, metastasis, and fatty acid metabolism through the miR-653-5p/HMGA2 axis [176].